Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Public ClinicalTrials.gov record NCT06990269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Study identification
- NCT ID
- NCT06990269
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- ADARx Pharmaceuticals, Inc.
- Industry
- Enrollment
- 240 participants
Conditions and interventions
Interventions
- ADX-038 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2025
- Primary completion
- Feb 27, 2030
- Completion
- Aug 29, 2030
- Last update posted
- Jun 15, 2026
2025 – 2030
United States locations
- U.S. sites
- 19
- U.S. states
- 8
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ADARx Clinical Site | Gilbert | Arizona | 85297 | Recruiting |
| ADARx Clinical Site | Phoenix | Arizona | 85020 | Recruiting |
| ADARx Clinical Site | Bakersfield | California | 93309 | Recruiting |
| ADARx Clinical Site | Beverly Hills | California | 90211 | Recruiting |
| ADARx Clinical Site | Huntington Beach | California | 93647 | Recruiting |
| ADARx Clinical Site | Poway | California | 92064 | Recruiting |
| ADARx Clinical Site | Orlando | Florida | 32806 | Recruiting |
| ADARx Clinical Site | Wildwood | Florida | 34785 | Recruiting |
| ADARx Clinical Site | Hagerstown | Maryland | 21740 | Recruiting |
| ADARx Clinical Site | Reno | Nevada | 89502 | Recruiting |
| ADARx Clinical Site | Erie | Pennsylvania | 16505 | Withdrawn |
| ADARx Clinical Site | Austin | Texas | 78705 | Recruiting |
| ADARx Clinical Site | Bellaire | Texas | 77401 | Recruiting |
| ADARx Clinical Site | Dallas | Texas | 75231 | Recruiting |
| ADARx Clinical Site | McAllen | Texas | 78503 | Recruiting |
| ADARx Clinical Site | Round Rock | Texas | 78681 | Recruiting |
| ADARx Clinical Site | San Antonio | Texas | 78340 | Recruiting |
| ADARx Clinical Site | The Woodlands | Texas | 77384 | Recruiting |
| ADARx Clinical Site | St. George | Utah | 84790 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06990269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06990269 live on ClinicalTrials.gov.